Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Evaluation of Interprofessional Team Disclosure of a Medical Error to a Simulated Patient.

Ragucci KR, Kern DH, Shrader SP.

Am J Pharm Educ. 2016 Oct 25;80(8):138.

2.

Are fourth-year medical students as prepared to manage unstable patients as they are to manage stable patients?

McEvoy MD, Dewaay DJ, Vanderbilt A, Alexander LA, Stilley MC, Hege MC, Kern DH.

Acad Med. 2014 Apr;89(4):618-24. doi: 10.1097/ACM.0000000000000192.

3.

Simulation curriculum can improve medical student assessment and management of acute coronary syndrome during a clinical practice exam.

DeWaay DJ, McEvoy MD, Kern DH, Alexander LA, Nietert PJ.

Am J Med Sci. 2014 Jun;347(6):452-6. doi: 10.1097/MAJ.0b013e3182a562d7.

4.

Simulation-based teaching to improve cardiovascular exam skills performance among third-year medical students.

Kern DH, Mainous AG 3rd, Carey M, Beddingfield A.

Teach Learn Med. 2011 Jan;23(1):15-20. doi: 10.1080/10401334.2011.536753.

PMID:
21240777
5.

Medical University of South Carolina College of Medicine.

Wong JG, Hazen-Martin DJ, Kern DH.

Acad Med. 2010 Sep;85(9 Suppl):S525-7. doi: 10.1097/ACM.0b013e3181ea68a0. No abstract available.

PMID:
20736622
6.

Applying Theory to Assess Cultural Competency.

Blue AV, Thiedke C, Chessman AW, Kern DH, Keller A.

Med Educ Online. 2005 Dec;10(1):4378. doi: 10.3402/meo.v10i.4378.

PMID:
28253150
7.

Medical students' perceptions of rural practice following a rural clerkship.

Blue AV, Chessman AW, Geesey ME, Garr DR, Kern DH, White AW.

Fam Med. 2004 May;36(5):336-40.

8.

A collaborative clerkship with a focus on rural community health.

Blue AV, Kern DH, Chessman AW, Garr DR, Fowler SD, Lamar S, Kammermann SK, Baxley EG, Lahoz MR, White AW, Bellack JP, West VT, Faulkner LR, McCurdy L.

J S C Med Assoc. 2001 Sep;97(9):383-4, 387-9.

PMID:
11584497
9.
11.

Heterogeneity of drug resistance in human breast and ovarian cancers.

Kern DH.

Cancer J Sci Am. 1998 Jan-Feb;4(1):41-5.

PMID:
9467045
12.

Tumor chemosensitivity and chemoresistance assays.

Kern DH.

Cancer. 1997 Apr 1;79(7):1447-50. No abstract available.

PMID:
9083168
13.

Prognostic implications of chemoresistance-sensitivity assays for colorectal and appendiceal cancer.

Fernandez-Trigo V, Shamsa F, Vidal-Jové J, Kern DH, Sugarbaker PH.

Am J Clin Oncol. 1995 Oct;18(5):454-60.

PMID:
7572768
14.
15.

Prediction of drug resistance in cancer chemotherapy: the Kern and DiSC assays.

Weisenthal LM, Kern DH.

Oncology (Williston Park). 1991 Sep;5(9):93-103; disc. 104, 111-4, 117-8. Review.

PMID:
1835882
16.
17.

In vitro and in vivo cytotoxicity of rhodamine 123 combined with hyperthermia.

Goffney WH, Wong JH, Kern DH, Chase D, Krag DN, Storm FK.

Cancer Res. 1990 Feb 1;50(3):459-63.

18.

Ganglioside composition of human melanoma and response to antitumor treatment.

Kono K, Tsuchida T, Kern DH, Irie R.

Cancer Invest. 1990;8(2):161-7.

PMID:
2400937
19.

Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues.

Nagourney RA, Messenger JC, Kern DH, Weisenthal LM.

Cancer Chemother Pharmacol. 1990;26(5):318-22.

PMID:
1698567
20.

In vitro testing of chemotherapeutic combinations in a rapid thymidine incorporation assay.

Sondak VK, Korn EL, Kern DH.

Int J Cell Cloning. 1988 Nov;6(6):378-91.

PMID:
3230328
21.

Structure-activity relationships defining the cytotoxicity of catechol analogues against human malignant melanoma.

Kern DH, Shoemaker RH, Hildebrand-Zanki SU, Driscoll JS.

Cancer Res. 1988 Sep 15;48(18):5178-82.

22.

In vitro assays to predict drug sensitivity and drug resistance. A panel discussion.

McGuire WL, Kern DH, Von Hoff DD, Weisenthal LM.

Breast Cancer Res Treat. 1988 Sep;12(1):7-21. No abstract available.

PMID:
3196887
23.

Testing chemotherapeutic combinations in the Human Tumor Colony--Forming Assay.

Sondak VK, Korn EL, Morton DL, Kern DH.

J Surg Oncol. 1988 Mar;37(3):156-60.

PMID:
3352269
24.

Thermal resistance of human malignant melanoma modulated by prostaglandin E2.

Kern DH, Krag DN, Kauffman GL Jr, Morton DL, Storm FK.

J Surg Oncol. 1988 Jan;37(1):60-4.

PMID:
3422097
25.

Relationship between in vitro tumor stem cell assay and in vivo antitumor activity using the P388 leukemia.

Marsh JC, Shoemaker RH, Salmon SE, Kern DH, Venditti JM.

Int J Cell Cloning. 1988 Jan;6(1):60-8.

PMID:
3339266
26.
27.

Effects of hormonal growth factors on colony formation and chemosensitivity of human tumors in agarose.

Kern DH, Chien FW, Goodwein SN, Sondak VK.

In Vitro Cell Dev Biol. 1987 Dec;23(12):863-6.

PMID:
3320016
28.

Clinical application of the thymidine incorporation assay.

Kern DH, Sondak VK, Morgan CR, Hildebrand-Zanki SU.

Ann Clin Lab Sci. 1987 Nov-Dec;17(6):383-8.

PMID:
3688821
29.
30.

Growth inhibitory effect of sodium azide in chemosensitivity assays.

Sondak VK, Hildebrand-Zanki SU, Butler A, Kern DH.

Int J Cell Cloning. 1987 May;5(3):191-201.

PMID:
2439615
31.

A radioimmunometric assay for the detection and characterization of lung cancer-associated antibodies in sera of lung cancer patients.

Hatzitheofilou C, Kern DH, Gupta RK, Campbell MA, Morton DL.

J Surg Res. 1987 Jan;42(1):85-91.

PMID:
2433504
32.

Prospective correlative chemosensitivity testing in high-dose intraarterial chemotherapy for liver metastases.

Link KH, Aigner KR, Kuehn W, Schwemmle K, Kern DH.

Cancer Res. 1986 Sep;46(9):4837-40.

33.

A rapid bioassay to determine stabilities of anticancer agents under conditions of the clonogenic assay.

Hildebrand-Zanki SU, Kern DH.

In Vitro Cell Dev Biol. 1986 May;22(5):247-52.

PMID:
3710996
34.

Development of a miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors.

Kern DH, Drogemuller CR, Kennedy MC, Hildebrand-Zanki SU, Tanigawa N, Sondak VK.

Cancer Res. 1985 Nov;45(11 Pt 1):5436-41.

35.

Analysis of the clinical utility of a predictive chemosensitivity assay.

Korn EL, Sondak VK, Bertelsen CA, Kern DH.

Stat Med. 1985 Oct-Dec;4(4):527-34.

PMID:
2418477
36.

[Scintillation assay for evaluating chemosensitivities of human tumors--the basic principle and clinical utility].

Tanigawa N, Takada Y, Morimoto H, Katoh Y, Maruhashi K, Nakanishi M, Tanaka T, Hashimura T, Sondak VK, Kern DH, et al.

Nihon Gan Chiryo Gakkai Shi. 1985 Jun 20;20(5):976-83. Japanese. No abstract available.

PMID:
4056552
37.

Application of a human tumor colony-forming assay to new drug screening.

Shoemaker RH, Wolpert-DeFilippes MK, Kern DH, Lieber MM, Makuch RW, Melnick NR, Miller WT, Salmon SE, Simon RM, Venditti JM, et al.

Cancer Res. 1985 May;45(5):2145-53.

38.

Evolution and clinical application of a rapid chemosensitivity assay.

Sondak VK, Bertelsen CA, Kern DH, Morton DL.

Cancer. 1985 Mar 15;55(6):1367-71.

PMID:
3971305
39.

In vitro sensitivity of breast carcinoma to combination chemotherapy.

Sondak VK, Bertelsen CA, Giuliano AE, Morton DL, Kern DH.

Curr Surg. 1984 Nov-Dec;41(6):470-2. No abstract available.

PMID:
6518815
40.

Breast cancers: estrogen and progesterone receptor status as a predictor of in vitro chemotherapeutic response.

Bertelsen CA, Giuliano AE, Kern DH, Mann BD, Roe DJ, Morton DL.

J Surg Res. 1984 Oct;37(4):257-63.

PMID:
6482418
41.

[Clinical correlations of drug sensitivity in the human tumor clonogenic assay--heterogeneity in drug sensitivity of human tumors].

Tanigawa N, Hikasa Y, Kern DH.

Gan No Rinsho. 1984 Jul;30(9 Suppl):1152-7. Japanese.

PMID:
6471422
42.
43.

Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay.

Tanigawa N, Mizuno Y, Hashimura T, Honda K, Satomura K, Hikasa Y, Niwa O, Sugahara T, Yoshida O, Kern DH, et al.

Cancer Res. 1984 Jun;44(6):2309-12.

44.

Clinical correlations with chemosensitivities measured in a rapid thymidine incorporation assay.

Sondak VK, Bertelsen CA, Tanigawa N, Hildebrand-Zanki SU, Morton DL, Korn EL, Kern DH.

Cancer Res. 1984 Apr;44(4):1725-8.

45.

Chemosensitivity testing of human solid tumors. A review of 1582 assays with 258 clinical correlations.

Bertelsen CA, Sondak VK, Mann BD, Korn EL, Kern DH.

Cancer. 1984 Mar 15;53(6):1240-5.

PMID:
6692313
46.

Present status of chemosensitivity assays.

Kern DH, Bertelsen CA.

Int Adv Surg Oncol. 1984;7:187-213. No abstract available.

PMID:
6469373
47.
48.

Predictability of response to clinical thermochemotherapy by the clonogenic assay.

Mann BD, Storm FK, Morton DL, Bertelsen CA, Korn EL, Kaiser LR, Kern DH.

Cancer. 1983 Oct 15;52(8):1389-94.

PMID:
6616404
49.

Biopsy of thoracic neoplasms for assay of chemosensitivity. New indication for thoracotomy.

Bertelsen CA, Kern DH, Kaiser LR, Mann BD, Holmes EC, Morton DL.

Arch Surg. 1983 Sep;118(9):1074-6.

PMID:
6615218
50.

New advances in surgical oncology.

Morton DL, Eilber FR, Storm FK, Kern DH.

West J Med. 1983 Sep;139(3):342-50. Review. No abstract available.

Supplemental Content

Support Center